Immunization With Second-Generation Genetically Attenuated Parasite Is Safe, Provides Strong Protection From Malaria Infection In Young Adults, Trial Shows

MedPage Today (11/21, Vaida) reports, “Immunization with a second-generation genetically attenuated parasite was safe and provided strong protection from malaria infection in young adults, a small clinical trial in the Netherlands suggested.” Researchers found that “protective efficacy against malaria infection occurred in eight of nine participants (89%) receiving a late-liver-stage attenuated malaria parasite.” The findings were published in the New England Journal of Medicine.